National Consumers League supports Questran switch contingent on consumer education.
This article was originally published in The Tan Sheet
Executive Summary
NATIONAL CONSUMERS LEAGUE SUPPORT FOR QUESTRAN SWITCH CONTINGENT on "several levels of consumer education and information," NCL President Linda Golodner said at the May 13 FDA advisory committee meeting on the switch. She emphasized that "to educate the consumer about the safe and effective use of this medication as an OTC drug will take careful and continued reinforcement by health professionals and by the industry."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning